Chrome Extension
WeChat Mini Program
Use on ChatGLM

新型2型糖尿病治疗药物Liraglutide

Shanghai Medical & Pharmaceutical Journal(2008)

Cited 0|Views6
No score
Abstract
Liraglutide(NN2211,NNC901170)是天然存在的胰高血糖素样多肽-1(GLP-1)类似物,性质稳定,口服一日1次.该药物以葡萄糖依赖方式发挥作用,只有当血糖高于正常值时才刺激胰岛素分泌和抑制胰高血糖素分泌,因此不会引起严重的低血糖不良反应.该药物由丹麦诺和诺德公司开发,目前处于II 期临床开发阶段.除了2型糖尿病外,在药物调节食欲方面也有应用潜力.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined